<DOC>
	<DOCNO>NCT02061124</DOCNO>
	<brief_summary>Accumulating evidence suggest bile acid bacteria intestine may constitute essential component complex mechanism regulate gut hormone secretion glucose homeostasis . At time , bile acid gut bacteria interdependent . Thus , likely modification enterohepatic circulation bile acid lead change gut hormone secretion gut bacteria composition consequently affect glucose homeostasis . The current study human interventional study 7-day ingestion bile acid sequestrant placebo , precede follow meal test faecal sampling . The aim examine ( ) bile acid sequestration influence postprandial glucagon-like peptide-1 ( GLP-1 ) secretion , gut microbiota glucose homeostasis patient type 2 diabetes healthy individual . As tool sequester bile acid use sevelamer , phosphate binding resin use treatment hyperphosphataemia adult patient chronic kidney disease . Surprisingly , sevelamer recently show improve glycaemic control patient chronic kidney disease type 2 diabetes . The investigator hypothesize high luminal concentration bile acid distal gut elicit change postprandial gut hormone secretion gut bacteria composition . The current study help clarify hypothesis improve general understand association bile acid circulation signalling , gut hormone secretion , gut bacteria glucose metabolism .</brief_summary>
	<brief_title>Effect Bile Acid Sequestration Postprandial GLP-1 Secretion , Glucose Homeostasis Gut Microbiota</brief_title>
	<detailed_description />
	<mesh_term>Sevelamer</mesh_term>
	<mesh_term>Bile Acids Salts</mesh_term>
	<criteria>Both group Caucasian ethnicity Normal haemoglobin Age 35 year 80 year Informed write consent BMI &gt; 23 kg/m2 &lt; 35 kg/m2 Patients type 2 diabetes Type 2 diabetes least 3 month Diagnosed accord criterion World Health Organization ( WHO ) Healthy Subjects Normal fast plasma glucose ( FPG ) &lt; 6.5 mM Normal glycated haemoglobin ( HbA1c ) &lt; 6.0 % Both group Liver disease ( alanine aminotransferase ( ALAT ) and/or serum aspartate aminotransferase ( ASAT ) &gt; 2 time normal value ) history hepatobiliary disorder Gastrointestinal disease , previous intestinal resection , cholecystectomy major intraabdominal surgery Hypo hyperphosphataemia Nephropathy ( serum creatinine &gt; 150 ÂµM and/or albuminuria Treatment medicine pause 12 hour Intake antibiotic six month prior study Hypo hypercalcaemia Hypo hyperthyroidism Treatment oral anticoagulant Active recent malignant disease Any treatment condition require acute subacute medical surgical intervention Lack effective birth control premenopausal woman Positive pregnancy test study day premenopausal woman Tobacco smoke Any condition consider incompatible participation investigator Patients type 2 diabetes Treatment insulin Treatment incretinbased therapy Healthy Subjects Diabetes prediabetes ( fast plasma glucose level &gt; 6.5 mM HbA1c &gt; 6.0 % ) Firstdegree relatives diabetes</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>